These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6152218)
1. B-HT 958--an antagonist at alpha 2-adrenoceptors and an agonist at dopamine autoreceptors in the brain. Hörtnagl H; Pichler L; Holzer-Petsche U; Hornykiewicz O; Kobinger W Eur J Pharmacol; 1984 Nov; 106(2):335-44. PubMed ID: 6152218 [TBL] [Abstract][Full Text] [Related]
2. B-HT 958 stimulates dopamine autoreceptors but blocks noradrenaline autoreceptors in the brain. Grabowska-Andén M; Andén NE J Pharm Pharmacol; 1984 Nov; 36(11):748-52. PubMed ID: 6150978 [TBL] [Abstract][Full Text] [Related]
3. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment. Hinzen D; Hornykiewicz O; Kobinger W; Pichler L; Pifl C; Schingnitz G Eur J Pharmacol; 1986 Nov; 131(1):75-86. PubMed ID: 3816949 [TBL] [Abstract][Full Text] [Related]
4. Alpha 2-adrenoceptor blocking properties of the alpha 1-selective agonist 2-(2-chloro-5-trifluoromethylphenylimino)imidazolidine (St 587). Pichler L; Kobinger W Arzneimittelforschung; 1985; 35(1A):201-5. PubMed ID: 2859026 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of B-HT 958, an alpha-adrenoceptor agonist with a high pre/postsynaptic activity ratio. Kobinger W; Pichler L Eur J Pharmacol; 1984 Jan; 97(1-2):67-73. PubMed ID: 6141948 [TBL] [Abstract][Full Text] [Related]
6. Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain. Andén NE; Nilsson H; Ros E; Thornström U Acta Pharmacol Toxicol (Copenh); 1983 Jan; 52(1):51-6. PubMed ID: 6301216 [TBL] [Abstract][Full Text] [Related]
7. B-HT 958 lowers blood pressure and heart rate in the rat through stimulation of dopamine receptors. Brown MJ; Harland D Br J Pharmacol; 1986 Feb; 87(2):361-70. PubMed ID: 3006858 [TBL] [Abstract][Full Text] [Related]
8. Stimulation of postsynaptic D2- dopamine receptors by B-HT 958 is revealed by co-treatment with the D1- receptor agonist SKF 38393. Andén NE; Grabowska-Andén M J Pharm Pharmacol; 1989 Jul; 41(7):490-2. PubMed ID: 2570858 [TBL] [Abstract][Full Text] [Related]
9. On the presence of autoreceptors on dopamine neurons in different brain regions. Andén NE; Grabowska-Andén M; Liljenberg B J Neural Transm; 1983; 57(3):129-37. PubMed ID: 6139410 [TBL] [Abstract][Full Text] [Related]
10. Possible function of alpha 1-adrenoceptors in the CNS in anaesthetized and conscious animals. Pichler L; Kobinger W Eur J Pharmacol; 1985 Jan; 107(3):305-11. PubMed ID: 2984009 [TBL] [Abstract][Full Text] [Related]
11. B-HT 920 and B-HT 958: presynaptic effects on electrically evoked 3H-dopamine release from slices of rat nucleus accumbens. Cichini G; Placheta P; Singer EA Naunyn Schmiedebergs Arch Pharmacol; 1987 Jan; 335(1):28-31. PubMed ID: 2883584 [TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor mediated hypothermic action of B-HT 920 in rats. Verma A; Kulkarni SK J Pharm Pharmacol; 1991 Jun; 43(6):421-4. PubMed ID: 1681056 [TBL] [Abstract][Full Text] [Related]
13. The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat. Pifl C; Pichler L; Kobinger W; Hornykiewicz O Eur J Pharmacol; 1988 Aug; 153(1):33-44. PubMed ID: 2463928 [TBL] [Abstract][Full Text] [Related]
14. Modulation of motor activity by alpha 1- and alpha 2-adrenoceptor stimulation in mice. Pichler L; Kobinger W Naunyn Schmiedebergs Arch Pharmacol; 1981 Sep; 317(2):180-2. PubMed ID: 6117802 [TBL] [Abstract][Full Text] [Related]
15. B-HT 958, a new alpha-adrenoceptor agonist with a high pre/postsynaptic activity ratio. Pichler L; Hörtnagl H; Kobinger W Naunyn Schmiedebergs Arch Pharmacol; 1982 Aug; 320(2):110-4. PubMed ID: 6126817 [TBL] [Abstract][Full Text] [Related]
16. Centrally mediated cardiovascular effects of B-HT 920 (6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo-[4,5-d]-azepine dihydrochloride), a hypotensive agent of the "clonidine type". Pichler L; Kobinger W J Cardiovasc Pharmacol; 1981; 3(2):269-77. PubMed ID: 6166798 [TBL] [Abstract][Full Text] [Related]
17. Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively. Andén NE; Gołembiowska-Nikitin K; Thornström U Naunyn Schmiedebergs Arch Pharmacol; 1982 Nov; 321(2):100-4. PubMed ID: 6296699 [No Abstract] [Full Text] [Related]
18. The putative dopamine autoreceptor agonist B-HT 920 decreases nigral dopamine cell firing rate and prolactin release in rat. Eriksson E; Svensson K; Clark D Life Sci; 1985 May; 36(19):1819-27. PubMed ID: 3990512 [TBL] [Abstract][Full Text] [Related]
19. B-HT 920 antagonizes rat neophobia in the X-maze test: a comparative study with other drugs active on adrenergic and dopaminergic receptors. Ferrari F; Tartoni PL; Mangiafico V Arch Int Pharmacodyn Ther; 1989; 298():7-14. PubMed ID: 2569300 [TBL] [Abstract][Full Text] [Related]
20. Demonstration of autoreceptors on dopamine neurons in different brain regions of rats treated with gammabutyrolactone. Andén NE; Grabowska-Andén M; Liljenberg B J Neural Transm; 1983; 58(3-4):143-52. PubMed ID: 6420514 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]